In the News: General News

New Eye Surgery Center Promises Convenience and Advanced Technology Under One Roof

Dayton, OH August 1, 2011 – Stahl Vision, the leader in cataract surgery and laser vision correction in Dayton, is excited to announce the opening of their new eye surgery center, Eye Laser & Surgery Center August 29, 2011. This state-of-the-art facility will offer comprehensive, advanced surgical services for patients including cataract removal, clear lens replacement and bifocal lens implants.

“We wanted to offer the latest technology in cataract surgery and bifocal implants, much like we have offered the latest technology in LASIK surgery for the last several years,” states Brian Stahl, MD, Medical Director and Refractive and Cataract Surgeon for Stahl Vision.

The new surgery center is conveniently located within the Stahl Vision building, 4235 Indian Ripple Road, off I-675 in Dayton. Over 4,000 square feet of new space was all built with the patient in mind. Providing eye surgery services in the same building patients go to for their pre and post op care, in place of a hospital, provides a new level of comfort and convenience. “It streamlines and simplifies the whole process of having cataract surgery for our patients.”

Stahl Vision has been at the forefront of eye care technology and techniques for almost two decades. Options for those with reading glasses, bifocals and cataracts are no exception. Doctors Brian Stahl and James Knowles are the most experienced surgeons in the area to offer advanced lens technologies that are helping thousands of patients reduce or eliminate their dependence on glasses while also freeing their vision from cataracts.

“The technology we have available to us is awesome. Nowhere else in the Miami Valley is this technology available all in one place.”

For more information about cataract surgery or clear lens replacement at Stahl Vision, patients can call 937-427-2020 or visit Stahl Vision also offers free LASIK examinations and general eye care within their Dayton location, 4235 Indian Ripple Road.


Mary Blackwell

Eye Laser & Surgery Center


Bausch & Lomb Introduces Crystalens® Aspheric Optic (AO) Accommodating Lens Implant (IOL): January 2010

Bausch & Lomb has received Food and Drug Administration (FDA) approval for and has released the Crystalens® AO, the first aberration-free accommodating intraocular lens (IOL) with aspheric optics, to Cataract Surgeons worldwide. Aspheric Intraocular Lens Implants (IOL)s are widely used during Cataract Surgery as patients report that they are able to achieve a better overall quality of vision and especially in dim or low light conditions. The Crystalens® AO has prolate aspheric surfaces and is designed to be free of spherical aberration. This design feature is intended to improve retinal image quality without compromising depth of field and therefore provides greater quality of distance and intermediate vision as well.

FDA Approves Aspheric AcrySof® IQ Toric Intraocular Lens: March 2009

Alcon announced that the FDA has approved the AcrySof® IQ Toric Intraocular Lens Implant for the correction of astigmatism during Cataract Surgery. This new lens offers an enhanced aspheric optic that improves image quality and increases contrast sensitivity in cataract surgery patients with astigmatism. The innovative lens design offers these patients the best opportunity for quality distance vision without glasses. According to company officials, the first AcrySof® Toric lens was introduced in 2005 and quickly became the leading toric lens on the market, due to its predictable power outcomes and excellent rotational stability. These benefits are largely realized due to the strengths of the AcrySof IOL material and proprietary single-piece design. As the first acrylic single-piece lens, AcrySof provides unequalled stability in the eye. This is especially important when correcting astigmatism, which occurs due to an irregular shape of the eye.

Tecnis® Multifocal Intraocular Lens Implant (IOL) Receives Food and Drug Administration (FDA) Approval: January 2009

The Tecnis® Multifocal IOL was developed by American Medical Optics, Inc., now called Abbot Medical Optics, using wavefront analysis of the human eye to create an aspheric surface that significantly reduces spherical aberration in order to provide patients with safer, sharper vision. In clinical studies the Tecnis® Multifocal has been found to provide good near, intermediate and far vision and thereby reduce spectacle dependency in patients who have undergone Cataract Surgery. Its optics incorporate “intelligent asphericity” to counteract most Corneal spherical aberrations. It is used for patients who desire multi-distance vision with reduced dependence on eyeglasses after Cataract Surgery.

FDA Approves Crystalens HD™ 4th Generation Accommodating

Lens Implant: June 2008

Bausch & Lomb received approval from the Food and Drug Administration (FDA) to market the Crystalens HD™ in the United States. The Crystalens Accommodating Intraocular Lens (IOL) was first approved by the FDA in November 2003. The Crystalens HD™ is the fourth generation of the only FDA approved accommodating lens. The surface of the Crystalens HD™ has been shaped to enhance the depth of focus with a proprietary optical modification. The enhanced optic provides an increased depth of focus, which is designed to improve near vision without compromising intermediate or distance vision. The HD lens does this without inducing increased undesirable dysphotopsia or night vision symptoms.

Common Prostate Drug Can Cause Problems With Cataract Surgery

American Academy of Ophthalmology: August 2006

A number of medical associations including the American Academy of Ophthalmology, the American Society of Cataract & Refractive and the American Urological Association have warned patients that the common prostrate drug, Flomax, and similar medications known as alpha-blockers may cause problems during cataract surgery. If you are taking Flomax and plan on having cataract surgery it is important that you alert your cataract surgeon before you have your surgery.

Flomax, commonly used to treat an enlarged prostate, and other alpha-blockers such as Hytrin, Cardura and Uroxatral can cause abnormal movement of muscles controlling the opening and closing of the iris and thus can interfere with pupil dilation, creating a condition known as Intraoperative Floppy Iris Syndrome. Your cataract surgeon will take extra precautions including additional eye drops if you are taking these medications in order to prevent unexpected complications during cataract surgery.

LASIK News from Stahl Vision

Wavefront Guided LASIK Produces Excellent Vision and Contrast

Journal of Cataract and Refractive Surgery: July 2009

Clinical researchers at the University of Waterloo School of Optometry reported on a study of Wavefront LASIK evaluating visual acuity and contrast sensitivity. The researchers found that 84% of patients achieved 20/20 vision or better with Wavefront LASIK vision correction and reported statistically significant improvement of contrast sensitivity. The improvement in contrast sensitivity is thought to translate into better overall vision performance in dim illumination and under poor lighting conditions.

Monovision LASIK Success

Current Opinions in Ophthalmology: June 2009

Researchers reported on factors that can effect the success and patient satisfaction with monovision LASIK including age, sex, ocular dominance, amount of monovision correction and degree of myopia, hyperopia and astigmatism and concluded that overall the most successful group are nearsighted women however the study concluded that monovision LASIK is quite suitable for farsighted patients as well.

Pilots Deploy Laser Sharp Vision

Ophthalmology Times: June 2009

According to an article by Lt. Col. Charles D. Reilly, M.D., Chief of Cornea/External Disease & Refractive Surgery at Wilford Hall Medical Center in San Antonio, Texas, Laser Eye Surgery for correcting common refractive eye problems such as nearsightedness, farsightedness and astigmatism has had “a remarkable record of safety and efficacy” among soldiers engaged in Operation Iraqi Freedom in Iraq and Operation Enduring Freedom in Afghanistan. Dr. Reilly has served as the Chief of the Warfighter Refractive Surgery center at Lackland Air Force Base in San Antonio and as a Refractive Surgery Consultant to the Air Force Surgeon General.

Dr. Reilly relayed, “As the Consultant for Refractive Surgery in the Air Force, I was interested primarily in what kinds of complications we were seeing in the patients on whom we performed refractive surgery, both before and after we get them deployed.” More that 15,000 members of the armed forces have LASIK or PRK each year. The most common complication was deploying too soon after surgery-often they were back in the active theater within 2 weeks of surgery. Dr. Reilly commented that trying to put your post operative “drops in your eyes while dodging bullets from the enemy is just not a good idea”. Overall the complication rate was pretty unremarkable with more military personnel coming back home with basketball injuries than refractive surgery complications. Even with a number of troops suffering significant eye trauma in the theaters, there were no flap dislocations in LASIK patients. He cautioned that this data was primarily for Air Force personnel and it is possible that the complication rate might have been higher among ground troops. The Army recently released a policy stating that personnel cannot deploy for 90 days following PRK, which Dr. Reilly feels, is a prudent course.

Joint LASIK Study Task Force

LASIK World Literature Review: Quality of Life and Patient Satisfaction.

Ophthalmology: April 2009

In March 2008 a team of Refractive Surgeons affiliated with the American Society of Cataract and Refractive Surgery, and researchers under the guidance of the American Academy of Ophthalmology and the United States Food and Drug Administration (FDA) performed a meta-analysis of 3,000 peer reviewed articles published over 10 years. Their analysis found a 95.4% patient satisfaction rate among LASIK patients worldwide.

Today, patients needing cataract surgery want more from their visual outcome. They want to know what they can expect from their results, minimal halos and glare and most of all, improved vision at all distances. That’s why Stahl Vision is proud to be one of the first in the region to offer the TECNIS Symfony Lens – the first and only presbyopia-correcting extended depth of focus lens.

The FDA approved this intraocular lens (IOL) that provides improved vision at near, intermediate, and far distances with less incidence of halo and glare post-operatively than other lens options.

Results from clinical-trials show the Tecnis Symfony IOL not only has a low occurrence of nighttime glare and halos similar to that of a standard monofocal lens while also providing continuous vision at all ranges without any drop-offs in between. In fact, 97% of patients in the trial indicated that they would elect to have the lens implanted again.

Dr. Stahl and Dr. Knowles offer a full range of vision correction procedures and work closely with every patient to determine the option best for them.

A new study finds contact lens (CL) users who chose to have LASIK were more satisfied with their vision a year after the surgery, and even more satisfied after two and even three years, according to Francis Price Jr., MD, and others with the Cornea Research Foundation of America. The study is the first to directly compare satisfaction rates of CL wearers (n=819) with those who opt for LASIK (n=694). Some key findings were: The proportion expressing strong satisfaction with CLs decreased from 63% at the start of the study to 54% at year three. Conversely, 88% of former CL users and 77% of former spectacle users reported being strongly satisfied with LASIK at year three, consistent with the high satisfaction levels at years one and two.

Latest Posts